Aug 28, 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).

Oct 15, 2024 · The Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.

Jan 7, 2025 · Getting a COVID-19 vaccine is a safer, more reliable way to build protection than getting sick with COVID-19. When are you up to date? Your child is up to date when they have received all recommended doses, including at least 1 dose of the 2024–2025 COVID-19 vaccine. 1 dose of the 2024–2025 Pfizer-BioNTech COVID-19 vaccine.

Previous COVID-19 vaccines are no longer available for use in the United States. FDA and CDC guidance is to check inventory and dispose of previous COVID-19 vaccines according to state and local regulations. for Consumers: EUA Recipient Fact Sheet - Pfizer-BioNTech COVID-19 Vaccine, 3mcg and 10mcg

The Pfizer–BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. [ 1 ] [ 2 ] [ 31 ] [ 40 ] The vaccine is used to reduce morbidity and mortality from COVID-19.

Aug 16, 2024 · Learn about the side effects of Pfizer-BioNTech COVID-19 Vaccine (COVID-19 mRNA (Pfizer) vaccine), from common to rare, for consumers and healthcare professionals.

Sep 16, 2024 · Pfizer-BioNTech COVID-19 vaccine 2024-2025 formula is authorized for people ages 6 months through 11 years. Comirnaty is approved for people age 12 and older. The vaccines that help protect against COVID-19 are safe and effective based on clinical trials and continued monitoring.

Dec 11, 2020 · COMIRNATY ® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech. It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older

Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated,...

Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as...